Literature DB >> 9586850

Benzodiazepine dependence: from neural circuits to gene expression.

J A Pratt1, R R Brett, D J Laurie.   

Abstract

The neural mechanisms underlying benzodiazepine dependence remain equivocal. The present studies tested the hypothesis that similar neural systems are recruited during diazepam tolerance and withdrawal, and that these are associated with changes in GABA(A) receptor properties. 2-Deoxyglucose quantitative autoradiography was employed to map the brain structures affected during chronic treatment and withdrawal from diazepam (5 mg/kg i.p. daily) in rats. Acute administration of diazepam evoked widespread reductions in local rates of cerebral glucose (LCGU) utilization throughout the brain. Brain structures associated with sensory processing developed tolerance to these depressant effects of diazepam after 3 days of treatment, whereas tolerance occurred in the Papez circuit of emotion after 28 days of treatment. These data suggest that adaptive changes in different neuroanatomical circuits may underlie tolerance to the various effects of diazepam. During flumazenil-precipitated withdrawal from diazepam there were marked increases in glucose use in structures of the Papez circuit, the nucleus accumbens, and the basolateral amygdala. These data suggest that the Papez circuit features strongly in diazepam tolerance and withdrawal and supports a common adaptive process being involved in these phenomena. While GABA enhancement of benzodiazepine binding was reduced in the nucleus accumbens after repeated diazepam treatment, there was little evidence to support adaptive changes in GABA(A) receptors or GABA(A) subunit gene expression (gamma2, alpha1, or alpha4) as underlying the functional changes in the identified circuits. Alternative neurochemical mechanisms, such as changes in glutamatergic function should be considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9586850     DOI: 10.1016/s0091-3057(97)00539-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

Review 1.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

2.  Duration of treatment and activation of α1-containing GABAA receptors variably affect the level of anxiety and seizure susceptibility after diazepam withdrawal in rats.

Authors:  Jovana Kovačević; Tamara Timić; Veera V Tiruveedhula; Bojan Batinić; Ojas A Namjoshi; Marija Milić; Srđan Joksimović; James M Cook; Miroslav M Savić
Journal:  Brain Res Bull       Date:  2014-03-30       Impact factor: 4.077

3.  Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?

Authors:  Christiaan H Vinkers; Berend Olivier
Journal:  Adv Pharmacol Sci       Date:  2012-03-29

4.  Agarwood Essential Oil Displays Sedative-Hypnotic Effects through the GABAergic System.

Authors:  Shuai Wang; Canhong Wang; Deqian Peng; Xinmin Liu; Chongming Wu; Peng Guo; Jianhe Wei
Journal:  Molecules       Date:  2017-12-09       Impact factor: 4.411

5.  Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice.

Authors:  Tomonori Furukawa; Yoshikazu Nikaido; Shuji Shimoyama; Nozomu Masuyama; Ayaka Notoya; Shinya Ueno
Journal:  Front Aging Neurosci       Date:  2021-11-26       Impact factor: 5.750

6.  Decoding the Synaptic Proteome with Long-Term Exposure to Midazolam during Early Development.

Authors:  Nghi M Nguyen; Neetha N Vellichirammal; Chittibabu Guda; Gurudutt Pendyala
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.